|
NL297170A
(https=)
|
1963-04-04 |
1900-01-01 |
|
|
|
NL128365C
(https=)
|
1963-11-05 |
|
|
|
|
US3449427A
(en)
|
1965-06-03 |
1969-06-10 |
Smithkline Corp |
Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes
|
|
US3697506A
(en)
|
1970-08-07 |
1972-10-10 |
Pfizer |
Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
|
|
US3686335A
(en)
|
1970-12-21 |
1972-08-22 |
Smith Kline French Lab |
5-vinyl-5h-di benzo(a,d)cycloheptenes
|
|
US4432987A
(en)
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
|
US4547505A
(en)
|
1983-03-25 |
1985-10-15 |
Degussa Aktiengesellschaft |
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
|
|
CS244821B2
(en)
|
1983-06-16 |
1986-08-14 |
Boehringer Ingelheim Ltd |
Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
|
|
DE3418167A1
(de)
|
1984-05-16 |
1985-11-21 |
Bayer Ag, 5090 Leverkusen |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden
|
|
DE3600288A1
(de)
|
1986-01-08 |
1987-07-16 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten
|
|
DE3618004A1
(de)
|
1986-05-28 |
1987-12-03 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten
|
|
CA2071897A1
(en)
|
1989-12-28 |
1991-06-29 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
|
DE69013131T2
(de)
|
1989-12-29 |
1995-05-24 |
Banyu Pharma Co Ltd |
2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate.
|
|
EP0531271A1
(en)
|
1991-08-22 |
1993-03-10 |
Monsanto Company |
Safening herbicidal pyrazolysulfonylureas
|
|
DE4131139A1
(de)
|
1991-09-19 |
1993-03-25 |
Bayer Ag |
Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure
|
|
KR100296810B1
(ko)
|
1993-03-12 |
2001-10-24 |
로렌스 티. 마이젠헬더 |
결정성세프티오퍼유리산
|
|
EP0793653A1
(en)
|
1994-11-23 |
1997-09-10 |
Neurogen Corporation |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
|
|
US5604253A
(en)
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
EP0968200A1
(en)
|
1997-02-24 |
2000-01-05 |
ZymoGenetics, Inc. |
Calcitonin mimetics
|
|
US6160134A
(en)
|
1997-12-24 |
2000-12-12 |
Bristol-Myers Squibb Co. |
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
|
|
TR200002182T2
(tr)
|
1998-01-27 |
2000-12-21 |
Aventis Pharmaceuticals Products Inc. |
İkame edilmiş aksozaherosayklil faktör xa inhibitörleri
|
|
US6268367B1
(en)
|
1998-02-23 |
2001-07-31 |
Zymogenetics, Inc. |
Piperazine derivatives for treating bone deficit conditions
|
|
EP1090919A4
(en)
|
1998-06-26 |
2002-05-22 |
Chugai Pharmaceutical Co Ltd |
FINE POWDER OF L-ALPHA-AMINOADIPIC ACID DERIVATIVES, SOLID PREPARATIONS FOR ORAL USE AND A METHOD FOR TREATING Loose POWDER
|
|
HK1043360A1
(zh)
|
1999-01-08 |
2002-09-13 |
Neurogen Corporation |
1-苯基-4-(1-[2-芳基]环丙基)甲基哌嗉：多巴胺受体配体
|
|
US6284761B1
(en)
|
1999-01-08 |
2001-09-04 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
|
|
AU5426500A
(en)
|
1999-06-16 |
2001-01-02 |
Takeda Chemical Industries Ltd. |
Benzazepine derivatives, process for the preparation of the same and uses thereof
|
|
AU7715300A
(en)
|
1999-09-27 |
2001-04-30 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
EP1248869A2
(en)
|
2000-01-07 |
2002-10-16 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US6521619B2
(en)
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
NZ523444A
(en)
|
2000-06-29 |
2004-12-24 |
Abbott Lab |
Aryl phenylcyclopropyl sulphide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
EP1301484A2
(en)
|
2000-07-20 |
2003-04-16 |
Neurogen Corporation |
Capsaicin receptor ligands
|
|
US6888012B2
(en)
|
2000-12-25 |
2005-05-03 |
Ajinomoto Co., Inc. |
Process for producing optically active halohydrin compound
|
|
PL364625A1
(en)
|
2001-02-23 |
2004-12-13 |
Merck & Co, Inc. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
|
ATE449090T1
(de)
|
2001-07-02 |
2009-12-15 |
High Point Pharmaceuticals Llc |
Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
|
|
EP1422228A1
(en)
|
2001-08-08 |
2004-05-26 |
Takeda Chemical Industries, Ltd. |
BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
|
|
WO2003026572A2
(en)
|
2001-09-26 |
2003-04-03 |
Merck & Co., Inc. |
Crystalline forms of ertapenem sodium
|
|
WO2003037271A2
(en)
|
2001-10-30 |
2003-05-08 |
Millennium Pharmaceuticals,Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6861432B2
(en)
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
JP2005526800A
(ja)
|
2002-03-22 |
2005-09-08 |
エルジー・ライフ・サイエンシーズ・リミテッド |
（２Ｓ）−Ｎ−５−［アミノ（イミノ）メチル］−２−チエニルメチル−１−（２Ｒ）−２−［（カルボキシルメチル）アミノ］−３，３−ジフェニルプロパノイル−２−ピロリジンカルボキサミド・ｎＨ２Ｏの新しい結晶形
|
|
WO2003103666A2
(en)
|
2002-06-07 |
2003-12-18 |
Altana Pharma Ag |
Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
|
|
US20040077618A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
US20040209858A1
(en)
|
2002-10-22 |
2004-10-21 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
WO2004046110A1
(ja)
|
2002-11-15 |
2004-06-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
メラニン凝集ホルモン受容体拮抗剤
|
|
DE60318891T2
(de)
|
2002-12-13 |
2009-01-22 |
Smithkline Beecham Corp. |
Cyclopropylverbindungen als ccr5 antagonisten
|
|
CA2523431A1
(en)
|
2003-04-23 |
2004-11-25 |
Glaxo Group Limited |
Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
|
|
EP2385041B1
(en)
|
2003-05-01 |
2013-09-18 |
Bristol-Myers Squibb Company |
Pyrazole-amine compounds useful as kinase inhibitors
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
RU2006125441A
(ru)
|
2003-12-15 |
2008-01-27 |
Джапан Тобакко Инк. (Jp) |
Производные циклопропана и их фармацевтическое применение
|
|
ATE537830T1
(de)
|
2004-07-06 |
2012-01-15 |
Xenon Pharmaceuticals Inc |
Nicotinamid derivate und ihre verwendung als therapeutika
|
|
AR050865A1
(es)
|
2004-09-09 |
2006-11-29 |
Sanofi Aventis |
Derivados de 2- morfolino-4-pirimidona
|
|
CN101048397A
(zh)
|
2004-09-29 |
2007-10-03 |
三菱制药株式会社 |
作为τ蛋白激酶1抑制剂的6－（吡啶基）－4－嘧啶酮衍生物
|
|
JP2008516922A
(ja)
|
2004-10-15 |
2008-05-22 |
グラクソ グループ リミテッド |
ヒスタミン受容体リガンドとしてのピロリジン誘導体
|
|
JP2008525478A
(ja)
|
2004-12-27 |
2008-07-17 |
アストラゼネカ アクチボラグ |
神経系及び精神医学系障害の治療のための代謝共役型グルタミン酸受容体アゴニストとしてのピラゾロン化合物
|
|
EP1844052A1
(en)
|
2005-01-26 |
2007-10-17 |
Pharmacia & Upjohn Company LLC |
Thieno[2,3-d]pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
|
|
PE20061127A1
(es)
|
2005-02-15 |
2006-10-21 |
Glaxo Group Ltd |
Derivados de propanosulfonamida que potencian el receptor de glutamato
|
|
TWI385164B
(zh)
|
2005-02-17 |
2013-02-11 |
Astellas Pharma Inc |
Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II)
|
|
EP1874780A1
(en)
|
2005-03-25 |
2008-01-09 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors
|
|
WO2006103555A1
(en)
|
2005-03-28 |
2006-10-05 |
Pharmacia & Upjohn Company Llc |
4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
JP2008534571A
(ja)
|
2005-03-28 |
2008-08-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
血小板凝集阻害物質としての４−ピペラジニルチエノ［２，３−ｄ］ピリミジン化合物
|
|
WO2006103544A2
(en)
|
2005-03-28 |
2006-10-05 |
Pharmacia & Upjohn Company Llc |
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
JP2009501235A
(ja)
|
2005-07-15 |
2009-01-15 |
シェーリング コーポレイション |
癌処置において有用なキナゾリン誘導体
|
|
TW200740779A
(en)
|
2005-07-22 |
2007-11-01 |
Mitsubishi Pharma Corp |
Intermediate compound for synthesizing pharmaceutical agent and production method thereof
|
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
SI1948607T1
(sl)
*
|
2005-09-16 |
2010-07-30 |
Janssen Pharmaceutica Nv |
Ciklopropil amini kot modulatorji histaminskega H3 receptorja
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
EP1951699B1
(en)
|
2005-10-31 |
2012-10-10 |
Janssen Pharmaceutica NV |
Processes for the preparation of cyclopropyl-amide derivatives
|
|
EP2316829A1
(en)
|
2005-12-21 |
2011-05-04 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
WO2007076140A2
(en)
|
2005-12-23 |
2007-07-05 |
University Of Cincinnati |
Treatment methods employing histamine h3 receptor antagonists, including betahistine
|
|
RU2008132966A
(ru)
|
2006-01-13 |
2010-02-20 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные циклогексилпиперазинилметанона и их применение в качестве модуляторов гистамин н3 рецептора
|
|
CN101384581B
(zh)
|
2006-02-17 |
2013-09-18 |
弗·哈夫曼-拉罗切有限公司 |
作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物
|
|
JP2009528240A
(ja)
|
2006-03-01 |
2009-08-06 |
セメンテク・ピーティーワイ・リミテッド |
メーソンリー部材用マトリックス及びその製造方法
|
|
JP2009132621A
(ja)
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
US7524848B2
(en)
|
2006-03-23 |
2009-04-28 |
Amgen Inc. |
Diaza heterocyclic amide compounds and their uses
|
|
WO2007138928A1
(ja)
|
2006-05-26 |
2007-12-06 |
Kaneka Corporation |
光学活性３－アミノ－２－ヒドロキシプロピオン酸シクロプロピルアミド誘導体およびその塩の製造方法
|
|
US9108948B2
(en)
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
BRPI0712823A2
(pt)
|
2006-06-23 |
2012-07-24 |
Abbott Lab |
derivados de ciclopropil amina como moduladores de receptor de histamina h3
|
|
AU2007271187A1
(en)
|
2006-07-03 |
2008-01-10 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Fused bicyclic compounds interacting with the histamine H4 receptor
|
|
WO2008024284A2
(en)
|
2006-08-21 |
2008-02-28 |
Merck & Co., Inc. |
Sulfonylated piperazines as cannabinoid-1 receptor modulators
|
|
TW200828371A
(en)
|
2006-09-21 |
2008-07-01 |
Matsushita Electric Industrial Co Ltd |
Chip-type filter
|
|
DE102006056526A1
(de)
|
2006-11-30 |
2008-06-05 |
Archimica Gmbh |
Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008147864A2
(en)
*
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
AU2008260647A1
(en)
|
2007-05-23 |
2008-12-11 |
Merck Sharp & Dohme Corp. |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
CA2688585A1
(en)
*
|
2007-06-11 |
2008-12-18 |
F. Hoffmann-La Roche Ag |
Cyclohexyl derivatives
|
|
DK2195293T3
(da)
*
|
2007-08-22 |
2014-02-03 |
Astrazeneca Ab |
Cyclopropylamidderivater
|
|
ES2460897T3
(es)
|
2007-10-04 |
2014-05-14 |
F. Hoffmann-La Roche Ag |
Derivados de ciclopropil aril amida y usos de los mismos
|
|
TW200934772A
(en)
|
2008-01-15 |
2009-08-16 |
Lilly Co Eli |
Crystalline(R)-2-(4-cyclopropanesulphonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
|
|
DE102008049371A1
(de)
|
2008-03-06 |
2009-09-10 |
Mühlbauer Ag |
Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür
|
|
CA2721303C
(en)
|
2008-05-08 |
2016-06-28 |
Evotec Ag |
Azetidines and cyclobutanes as histamine h3 receptor antagonists
|
|
JP2012503595A
(ja)
|
2008-07-28 |
2012-02-09 |
シダンスク ユニバーシティ |
代謝病の治療用の化合物
|
|
CN101462980B
(zh)
|
2009-01-05 |
2013-01-09 |
扬州天辰精细化工有限公司 |
2，6—二氟苯甲酰胺的工业化生产方法
|
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
|
US20110201622A1
(en)
*
|
2010-02-18 |
2011-08-18 |
Collins Craig D |
Solid Forms Comprising A Cyclopropyl Amide Derivative
|
|
BR112012020629A2
(pt)
|
2010-02-18 |
2018-06-19 |
Astrazeneca Ab |
forma cristalina, e, método para a terapia de um distúrbio
|